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ABSTRACT 
 
Background: Deliberate self-harm (DSH) and nonsuicidal self-injury (NSSI) are serious 
global health problems prevalent among both community and clinical samples. Several 
studies have suggested that aggression towards others may be a clinically relevant correlate in 
self-harming individuals, but the association is still unclear. Current research suggests that 
NSSI primarily serves an emotion regulating function, but there are few treatments directly 
targeting NSSI available. Thus, there is currently a need for research on the characteristics, 
clinical correlates and treatments for DSH and NSSI. 
Aims: The general aim of this thesis was to study DSH and NSSI and its association with 
violence towards others and to evaluate the utility of a short adjunctive treatment for NSSI. 
The specific aims of the individual studies were: 
• to compare suicidal severity and use of interpersonal violence in a group of suicide 
attempters with and without a history of NSSI (Study I).  
• to investigate the association between DSH and perpetration of violence towards 
others (Study II). 
• to evaluate the utility of a short, group-based behavioural treatment targeting emotion 
dysregulation and NSSI (Study III). 
• to examine what patient characteristics predicted outcomes in the treatment evaluated 
in Study III (Study IV). 
Methods: A cross sectional study was conducted examining the impact of comorbid NSSI in 
a group of suicide attempters (Study I). The unique association between DSH and violent 
crime was investigated through Cox proportional hazards regressions in a survival analysis 
based on register data (Study II). The utility and feasibility of a short, adjunctive treatment 
for NSSI (emotion regulation group therapy, ERGT) was evaluated in an open, uncontrolled 
pilot study. Within-group effects and interaction effects of predictors on outcome at post 
treatment and six-month follow-up was analysed using multilevel generalized estimated 
equations negative binomial and linear mixed regression models (Study III and IV).  
Results: Suicide attempters with comorbid NSSI engaged in more violent and frequent 
suicide attempts, and had used interpersonal violence towards others to a significantly higher 
extent than suicide attempters without NSSI. A significant and unique association between 
DSH and violent crime was found suggesting a shared vulnerability between violence 
towards oneself and others. ERGT was associated with significant reductions in NSSI, 
emotion dysregulation and other psychiatric symptoms at post-treatment and six-month 
follow-up. Analysing predictors of outcome revealed that ERGT may also be useful for 
individuals with high frequency of NSSI, and that comorbidity was negatively associated 
with the maintenance of treatment gains.  
Conclusions: Engagement in deliberate self-harm and violence towards others are associated, 
although what characterizes this shared vulnerability to violence against one self and others is 
yet unclear. ERGT may be a useful and transportable treatment for individuals with NSSI. 
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1 INTRODUCTION 
 
 
I began working with self-harming women with borderline personality disorder in 2002 as a 
clinical psychologist and continued to do that for the next 12 years. I have thoroughly 
enjoyed working with dialectical behaviour therapy (DBT) with these patients, patients that 
have been neglected and stigmatized within the psychiatric system for many years, and still 
are, unfortunately. One thing that has been striking during my years of training and working 
with DBT, are the many dedicated clinicians I have met. Clinicians who had invested a lot 
time and energy in learning DBT, a treatment they hoped would better help these patients 
than the treatments they had previously used. Most of them had implemented DBT into their 
clinics on their own initiative, creating study groups and forming treatment teams with other 
interested clinicians. A grassroots initiative if you will. Without this dedication, many self-
harming patients would not have had access to the treatments that are available today, such as 
DBT and mentalization based therapy.  
Against this background, it has been such a joy for me to have been given the opportunity to 
participate in a government funded effort to increase access to treatment for self-harm 
through the implementation and structured evaluation of a novel treatment into Swedish 
psychiatric outpatient clinics. To see that the dedication and initiative comes, this time, not 
only from clinicians but from our own government in the form of the National Self-harm 
project. And in implementing and evaluating ERGT, I have met yet many more dedicated 
clinicians. 
To have changed paths, from clinic to research has not been simple, but it has been extremely 
rewarding. I know that my clinical background has helped me form my research questions, 
particularly the focus on aggression in self-harming women and I hope that the research I 
have done will help self-harming patients and the clinicians working with them, in the future.  
 
Stockholm, winter 2018. 
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2 BACKGROUND 
 
2.1 SELF-HARM, DELIBERATE SELF-HARM AND NONSUICIDAL SELF-
INJURY 
Self-harm is a behaviour that involves the deliberate causing of pain or injury to oneself – 
usually as a way of coping with distressing or painful feelings and thoughts, and may also 
include attempted suicide. Self-harm has gained increasing attention in the research field over 
the past decades, as its prevalence in and negative impact on both community and clinical 
populations has become more evident1,2.  
 
2.1.1 Definition of the terms 
As self-harm came into focus as a clinical phenomenon in the early 1950’s, it was initially 
conceptualized as “attempted suicide”. However, clinicians and researchers soon realized that 
some of these attempted suicides were conducted without suicidal intent, and new terms were 
developed to better account for these differences. This led to a conceptual confusion as terms 
such as “parasucide”, “self-mutilation”, “self-injury”, “attempted suicide” and “deliberate 
self-harm” have been used interchangeably when studying non-fatal deliberate self-harm 
behaviour and attempted suicide. The term deliberate self-harm (DSH) has primarily been 
used within European research, and refers to non-fatal behaviours aimed at hurting oneself 
through self-injury or self-poisoning3 regardless of intent (i.e., both suicidal and non-
suicidal). DSH does not include other potentially self-harming behaviours such as starving 
oneself, exposing oneself to sexual (or other) risk, using drugs or alcohol, or piercing or 
tattooing one’s body. Self-harming behaviours included in DSH have been studied in 
European epidemiological studies since the mid 1970’s4,5 and has accumulated a large 
empirical base, resulting in clinical guidelines, interventions and treatments3,6,7. Researchers 
within this field have argued for the inclusion of both suicidal and non-suicidal self-harm due 
to difficulties in assessing intent within DSH, and because research shows that motivation for 
DSH may be both suicidal and non-suicidal at the same time, or may vary within an 
individual over time8,9. In recent years, several European researchers have suggested that the 
word “deliberate” (thought to distinguish voluntary from accidental self-harm) be removed 
when conceptualizing self-harm, as it has been experienced as increasing stigma around self-
harm. The term “deliberate” suggests a degree of control and wilfulness in the self-harming 
individual, although many of them experience that self-harm is not a choice but an 
unstoppable urge, and others self-harm during dissociative states, thus precluding 
“deliberation” when engaging in the self-harm behaviour3. 
Research on self-harm in the US began to flourish with the publications on parasuicidal 
behaviours in women with borderline personality disorder (BPD) conducted by Marsha 
Linehan10-12. Her behavioural conceptualization of self-harm as serving an emotion regulating 
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function in individuals with BPD and her development of dialectical behaviour therapy 
(DBT) inspired a non-judgmental view on self-harm and directed a new line of research and 
treatment. Although many North American researchers have used the term parasuicidal 
behaviour to describe both suicidal and non-suicidal self-harm, other terms such as self-
injury, self-mutilation, self-injurious behaviour and deliberate self-harm have also been 
applied. To confuse matters even more, the term DSH has been used when actually studying 
self-harm performed without suicidal intent and not including poisoning or intoxications (see 
for example13, and Studies III and IV in this thesis).  
In more recent years, the term NSSI has been introduced as a separate diagnosis in the 
“Conditions for further studies” in the DSM-514. Before then, self-harm was only described 
as one of nine diagnostic criteria for BPD (criteria no 5; ”recurrent suicidal behaviour, 
gestures, or threats, or self-mutilating behaviour”) leading to self-harming individuals 
oftentimes being erroneously diagnosed with BPD14. The construction of the NSSI-disorder 
was done in an effort to distinguish non-fatal, non-suicidal DSH from non-fatal self-harm 
with suicidal intent, to increase diagnostic precision and to promote research.  
NSSI is restricted to include self-harm behaviours directed to the skin and is defined as “the 
deliberate, direct destruction or alteration of body tissue without conscious suicidal intent, but 
resulting in injury severe enough for tissue damage (e.g., scarring) to occur” (p. 253)13. 
Researchers advocating NSSI as a separate diagnostic and clinical entity claim that there is a 
qualitative difference to self-harm behaviours performed to manage “everyday” emotions or 
frustrations as compared to self-harm in order to end one’s life15. Also, NSSI has been found 
to be highly prevalent in both community and clinical samples, indicating that it is a mental 
health problem in its own right, especially among adolescents16. European researchers have to 
some extent begun investigating NSSI as a separate phenomenon when studying DSH, in 
more recent years (for an example, see17). However, some conceptual confusion regarding 
these terms remains in the literature. 
Thus, NSSI is a specific form of DSH where nonsuicidal intent is assessed and confirmed by 
the individuals engaging in the behaviour. In the present thesis, NSSI was studied in Study I, 
III and IV, whereas DSH was studied in Study II, where intent was not possible to assess 
due to the large-scale registry based design.  
 
2.1.2 Prevalence and course 
Prevalence rates of DSH in community samples have been estimated to 13% in adolescents 
who have engaged in DSH once and 7% in adolescents who have self-harmed repeatedly. For 
adults the rate has been estimated to 4.6-6.6%3. Although prevalence rates are difficult to 
establish due to the conceptual differences described above, and the many different 
methodologies used when assessing self-harm, a systematic review, meta-analysis and meta-
regression of NSSI found a pooled prevalence rate in non-clinical samples to be around 17% 
in adolescents and 5.5% in adults18. In clinical samples, DSH has been studied most 
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extensively (compared to NSSI), and findings show that DSH is prevalent in adolescent 
clinical samples (30-40%)19 and adult psychiatric populations (20-50%; also including 
suicidal ideation)20. Among individuals with BPD, rates up to 75% have been reported21. 
Research has shown that the incidence of NSSI and DSH has increased among children and 
adolescents in the past years2. 
Both DSH and NSSI typically debut between 12 and 14 years of age and is most prevalent 
among 14-24 year olds22,23. Most studies indicate that girls debut earlier than boys24,25. The 
natural course of self-harm was investigated in a multi-wave cohort study of a community 
adolescent sample in Australia, and showed that most adolescents with DSH spontaneously 
remit by early adulthood26. However, those who did not remit, but continued into adulthood 
showed more frequent and versatile (i.e., using several types of) DSH and higher levels of 
emotional dysregulation27.  
 
2.1.3 Gender differences 
Although DSH and NSSI is more prevalent among women than men in most studies15,28,29 
some studies have challenged that notion24,30. However, in a recent meta-review, women had 
a small but significantly higher odds ratio of engagement in NSSI, especially in studies 
conducted in clinical samples31. Also, there is some evidence that women engage in more 
frequent DSH or NSSI  – typically cutting and scratching – whereas men engage in more low 
frequency NSSI or DSH of no specific method25,31.  
 
2.1.4 Characteristics and clinical correlates 
DSH and NSSI are associated with both externalizing and internalizing problems in 
adolescents and adults. Adolescent engagement in DSH is associated with comorbid 
depression, anxiety, anti-social behaviours, high-risk drug and alcohol use and smoking26 and 
is strongly associated with concurrent and future suicide attempts17,32.  
In adults, DSH has primarily been associated with BPD, a psychiatric disorder characterized 
by emotional instability, interpersonal difficulties, and identity disturbance33. However, as the 
interest for self-harm as a clinically relevant phenomenon in its own right has increased, 
recent research suggests that DSH and NSSI are prevalent in several patient populations not 
meeting criteria for BPD, e.g., other personality disorders, post-traumatic stress disorder 
(PTSD), substance use, eating disorders and mood- and anxiety disorders16,34,35. DSH and 
NSSI can also occur in the absence of any psychiatric comorbidity36. 
Interpersonal difficulties are highly relevant to both DSH and NSSI, and childhood abuse and 
neglect are distal risk factors for both37,38. Several studies have found a lack of family support 
and negative feelings for one’s parents or caregivers to be associated with DSH and NSSI in 
adolescents39-43. The role of lack of perceived peer support is still unclear, where some 
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studies have found significant associations with NSSI and others have not40. Also, 
interpersonal difficulties, such as separation or conflicts, often trigger DSH and NSSI, and is 
one of the highest ranking self-reported problems among adults presenting to the emergency 
department following DSH44,45. It has been suggested that interpersonal triggers may initiate 
a first episode of self-harm, and that other factors may influence repetition of self-harm, such 
as emotion dysregulation or lack of family support39. 
Substance abuse, particularly alcohol misuse, is highly prevalent among self-harming 
individuals46, and in a recent study from the UK, overconsumption of alcohol had increased 
as a self-reported problem among treatment seeking adults in the community44.  
Elevated self-reported levels of aggression have been found in several studies of individuals 
with DSH and NSSI and17,47-49. In a recent epidemiological prevalence study, adolescents 
with DSH and attempted suicide had higher levels of conduct disorder and intermittent 
explosive disorder than adolescents with suicidal ideation only50. In a longitudinal birth 
cohort study, early DSH (before age 24) was associated with a doubled risk for domestic 
abuse, criminal conviction and child removal by the social services compared to those 
without attempted suicide51. Interestingly, there were no gender differences. 
Thus, there are several clinical correlates associated with DSH and NSSI, and violence or 
aggression seems to be one such clinically relevant correlate that has not been extensively 
studied. Also, population based studies on psychiatric and clinical correlates of DSH are 
scarce, and gender differences are rarely investigated due to small, clinical samples. Against 
this background, Study I and II in this thesis sought to examine the role of interpersonal 
violence in DSH and NSSI. 
 
2.1.5 Predictor of suicide 
DSH includes attempted suicide, which is strongly linked to future completed suicide52-54. 
However, NSSI has also been identified as a strong risk factor for future suicidal behaviour30. 
Suicidal behaviours are complex and range over a broad spectrum of injury and severity and 
encompass both completed and attempted suicide as well as suicidal ideation and NSSI55. 
While NSSI, as previously mentioned, includes self-harm directed at bodily tissue and 
performed without suicidal intent, suicidal behaviours (i.e., attempted and/or completed 
suicide) are defined by the intention to terminate one’s own life56. Although NSSI and 
attempted suicide often co-occur and share several features, such as regulating both intra- and 
interpersonal distress they also differ in several ways; regarding for example intent, frequency 
and lethality. NSSI has been associated with increased risk for suicide attempts across 
different clinical and sociodemographic groups (for a review, see57). DSH and NSSI have 
repeatedly been found to predict attempted suicide over and above depression, hopelessness, 
family functioning, BPD-symptoms, PTSD and childhood abuse24,30,53,54,58. Also, several 
studies have shown a significant positive correlation between frequency of NSSI and suicide 
attempts and lethality of suicide attempts24,32,48.  
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Current research shows that individuals who engage in both NSSI and suicide attempts are a 
more troubled group than individuals with only NSSI or only suicide attempt, with more 
complex psychopathology and lower psychosocial functioning. Both adult and adolescent 
suicide attempters with NSSI feel more hopeless, lonely and angry, and engage in 
significantly more impulsive, risk taking behaviour and alcohol use than adolescent suicide 
attempters without NSSI-history15,17,32,42,48. In a recent longitudinal study of both DSH and 
NSSI, NSSI was associated with adverse social and mental health outcomes and individuals 
with DSH had even worse outcomes17. Thus, there seems to be a gradual increase in risk for 
adverse outcomes with self-harm that includes higher degrees of suicidal intent. 
DSH and NSSI are important factors to consider in suicide risk assessment; still, the 
conditions under which they may increase risk for suicidal behaviours or other adverse 
outcomes are unclear. Study I sought to examine the role of NSSI in suicide attempters, to 
investigate whether co-occurring NSSI was associated with more severe suicidal behaviours, 
and to study its association with interpersonal violence.  
 
2.1.6 Impulsive aggression 
Impulsive aggression is the tendency to react with hostility, impulsivity and aggression to 
frustrating or stressful events59. Impulsive aggression is differentiated from proactive 
aggression which is defined as a more controlled, instrumental and predatory aggression60. 
Impulsive aggression has repeatedly been associated with attempted and completed suicide, 
and has been suggested as an endophenotype for suicidal behaviours61, because it is 
associated with suicidal behaviours in the general population, has a heritability of 30-50%, is 
state independent, co-segregates within families and is associated with genes related to the 
serotonergic system62.  
Higher levels of self- or other reported aggression have quite consistently differentiated 
suicide attempters from non-attempters in both cross-sectional and longitudinal studies63-65, 
and in a longitudinal follow-up study of a male high-risk population, early DSH was 
associated with impulsive aggression and interpersonal violence66. It has been suggested that 
suicidal behaviours – not ideation – are part of the inherited impulsive aggressive traits67. 
Both emotion dysregulation and impulsive aggression have been suggested to act as 
mediators of DSH or NSSI in individuals with personality disorders68. Specifically, it has 
been suggested that emotion dysregulation mediates NSSI in depressed individuals, whereas 
impulsive aggression mediates NSSI in non-depressed self-harming individuals69.  
There is preliminary evidence of an increased co-occurrence of interpersonal violence in 
individuals with NSSI. Elevated levels of self-reported aggression was associated with NSSI 
in a large sample of community adolescents70 and was significantly associated with DSH in a 
longitudinal cohort study26. In a study of 122 community adolescents, the combination of 
both self-directed (criticism/self-doubt) and other-directed (criticism/aggression) hostility was 
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significantly related to NSSI, although rates of other-directed aggression were significantly 
higher among boys than girls71. Further, a cross sectional study of 2907 students, age 10-18 
found a significant association between NSSI and self-reported verbal, indirect aggression 
and hostility in both boys and girls. They did not however, find any significant associations 
between physical aggression, anger and NSSI72. Also, in a cross-sectional mediational study 
of in-patient adolescents, there was a significant association between aggression and NSSI, a 
relationship that was partially mediated by self-reported lack of parental support and fully 
mediated by cognitive biases (negative self-talk and negative cognitive style)40. Finally, DSH 
is common among both male and female prisoners73, and suicide risk has been found to be 
particularly high among female prisoners convicted of a violent crime74. 
Research on interpersonal violence in women is scarce, in part due to women committing 
fewer violent acts than men. However, some of the studies that do exist, suggest that violent 
women direct their violence towards intimate partners, friends and children to a higher extent 
than men75, although other findings contradict that76. It is however clear that violent females 
have high psychiatric comorbidity, particularly within personality disorders such as antisocial 
personality disorder (ASPD) and BPD, but also with anxiety and mood disorders, self-harm 
and early conduct disorder75,77. Being victims of childhood abuse and intimate partner 
violence is more common among violent females than males78-80. Alcohol abuse is common 
among both male and female violence perpetrators, and may for women be particularly 
related to violence directed towards strangers75,76.  
Individuals struggling with self-harm and violent behaviours rarely tell their treatment 
providers about these behaviours due to stigma81,82. Thus, although relevant to the treatment 
and assessment of self-harming individuals there is a lack of knowledge on the association 
between deliberate self-harm and interpersonal violence informing clinicians on how to 
address these behaviours. Most studies assessing violence in self-harming individuals, have 
been conducted on small, clinical cohorts or forensic populations, using many different 
definitions of self-harm and violence. Thus the ability to draw any firm conclusions on the 
co-occurrence of violence and self-harm is limited. Further, as many studies are conducted 
within clinical cohorts and self-harming females are more prone to seek treatment for self-
harm compared to males83, studies may be biased. Against this background, Study II was 
conducted in order to study the association between previous clinical care due to self-harm 
and violent crimes, including possible gender differences in a population-based cohort study. 
 
2.1.7 Self-harm as an emotion regulation strategy? 
Several theories have proposed that deficits in emotion regulation skills and a heightened (or 
lessened) reactivity to negative emotions coupled with a reduced tolerance for high arousal 
explain the engagement in and maintenance of NSSI84-86. The experiential avoidance model 
(EAM;85, see Figure 1), posits that NSSI is part of a response class of negatively reinforced 
behaviours (which may also include substance misuse, thought suppression or binge-eating 
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among others) and is maintained by the immediate relief from unwanted internal 
experiences85. Many studies have confirmed the association between negative emotional 
states preceding self-harm, particularly negative emotional experiences, such as anger, 
sadness, tension and fear, but also positive emotions as well as dissociative states and self-
punishment85,87,88. Research suggests that individuals who engage in NSSI have more 
difficulties identifying, expressing and regulating emotions34. Some studies suggest that self-
harming individuals also experience more negative affect and less positive affect, as well as 
more complex emotions that they have difficulties differentiating and identify89 and instead 
use self-harm to reduce negative emotional states87.  
Dysfunctional emotion regulation plays a central role in the development and maintenance of 
self-harming behaviours85,87 and has been defined as an impaired ability to flexibly and 
adaptively modulate the intensity and duration of emotional states and to control impulsive 
behaviours when distressed in order to facilitate engagement in non-mood dependent goal-
directed activities90. Thus, effective emotion regulation involves the ability to identify and 
label emotions, to accept and monitor emotions, to appropriately evaluate the information 
from emotions and to inhibit impulsive behaviours. Emotion dysregulation indicates 
difficulties in all these areas, leading to impulsive and inappropriate behaviours and efforts to 
avoid or control emotions instead of controlling one’s behaviours85,90. Although individuals 
who self-harm seem to have deficits in emotion regulation, both on a neurological level and a 
behavioural level, the evidence regarding trait emotional reactivity is mixed91. However, the 
EAM-model stipulates a poorer tolerance for aversive internal states. Thus, a general 
tendency to use avoidant coping strategies, in part due to emotion dysregulation and deficits 
in emotion regulation skills may predispose an individual to use NSSI to manage stressors. 
Apart from the intrapersonal, emotion regulating function of NSSI, other models have also 
focused on the interpersonal, or social reinforcement of NSSI (i.e.,23), as self-harm can be a 
means of communicating with others, and/or making others lessen demands perceived to be 
too high23.  
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Figure 1. A model of the Experiential Avoidance Model of NSSI. 
 
Thus, research suggests that DSH and NSSI are prevalent among both adults and adolescents 
and fills an emotion regulating function. Treatments targeting emotion dysregulation should 
be disseminated broadly in order to help self-harming individuals reduce NSSI.  
 
2.1.8 Shared vulnerabilities and maintaining mechanisms 
Why do impulsive aggression, violence and self-harm frequently co-occur? General patterns 
of emotion dysregulation have been found in individuals prone to both types of behaviours.  
Individuals vulnerable to impulsive aggression and DSH tend to have an increased autonomic 
arousal and a low tolerance for aversive events, particularly related to perceived or actual 
interpersonal threat60. It has been suggested that the expression of aggressive acts toward 
others (e.g., intimate partners) may serve an emotion regulating function through the release 
of tension and unwanted internal experiences, in line with findings from experimental 
studies90,92 and the EAM-model85.  
Regarding neurobiological correlates, serotonin dysfunction has been found in individuals 
with DSH as well as in individuals with impulsive aggression. Lower serotonin levels have 
been associated with aggression, depression and completed and attempted suicide, suggesting 
a common neurobiological link between aggression and suicidal behaviours60. In individuals 
with NSSI however, the association is unclear. A recent review concluded that serotonin 
deficiency was more related to aggressive and violent behaviours in general than to NSSI in 
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particular, although some evidence points toward that experimental reduction of serotonergic 
levels increased self-harm93.  
George and colleagues (2006) describe a link between interpersonal (domestic) violence and 
self-harm in a sample of 71 male and female perpetrators of domestic violence. In an 
interview-based study, they found that the perpetrators felt intense fear/rage, anxiety and a 
heightened autonomic arousal, accompanied by racing thoughts in situations that could lead 
to domestic abuse. George and colleagues hypothesized that aggressive acts mainly are 
conditioned fear responses (fight-or flight), where aggression typically happened when the 
perpetrators were unable to flee. Engagement in aggression was associated with an immediate 
relief, a relief that was not present when trying to cope with anxiety through fleeing the 
scene94. This description resembles to a high extent the EAM-model proposed by Chapman 
and colleagues, where self-harm is often engaged in to calm racing thoughts or to manage 
intolerable emotions the self-harming individual perceives he/she has no other way of 
managing85,87. Also, in an in-depth interview study on 13 women in forensic psychiatric care, 
participants described that self-harm and aggression were perceived to serve an emotion 
regulating function as a way of managing negative thoughts and feelings95. They perceived 
that violence and self-harm were both associated with a sense of relief and sometimes even 
happiness, and although they acknowledged that these strategies were destructive for them in 
the longer perspective, they felt they had no other means of regulating negative thoughts and 
emotions95. 
Thus, emotion dysregulation and emotional avoidance may be important factors in aggression 
towards others as well as when directed towards oneself. 
 
2.2 TREATMENTS TARGETING DSH AND/OR NSSI 
To date, no established pharmacological treatments specific to DSH or NSSI exist3 and 
psychosocial treatments for DSH or NSSI have primarily focused on individuals with BPD, 
as DSH is included in the DSM-IV and DSM-5 as a criterion for BPD14,33. In Swedish 
outpatient psychiatry, mainly two treatments are offered patients with DSH or NSSI – 
dialectical behaviour therapy (DBT) and mentalization-based therapy (MBT). They have both 
shown effect on DSH in individuals with BPD12,96,97, although a recent meta-analysis show 
that the effect size for DSH and BPD-related behaviours is small (Hedges g = 0.32; 95% CI, 
0.09-0.54), and treatment gains are unstable during follow-up98. Also, these treatments are 
specialized for BPD and aimed at treating all aspects of BPD. Both treatments are long-term 
(lasting 1-2 years) and require highly skilled therapists, precluding these treatments from 
being offered on large scale to all psychiatric patients who self-harm. Consequently, patients 
who engage in self-harm are offered a multitude of different treatments within Swedish 
psychiatric care, such as supportive counselling, standard cognitive-behavioural therapy, and 
psychodynamic or existential therapy, none of which have been investigated empirically for 
DSH or NSSI.  
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There is a need to increase availability of treatments that directly target NSSI, and not only 
for individuals meeting full criteria for BPD. Thus, shorter, and more easily implementable 
treatments for NSSI need to be disseminated into routine clinical care. Against this 
background, Study III evaluated the implementation of a short, group-based behavioural 
treatment for NSSI into routine clinical care. 
 
2.2.1 Emotion regulation group therapy 
Emotion regulation group therapy (ERGT) was developed by Gratz and colleagues99-101 in 
order to address the lack of shorter and more clinically feasible evidence-based treatments for 
DSH (i.e., NSSI) in individuals with BPD or subclinical BPD. It is based on an acceptance-
based definition of emotion regulation, which involves a) emotional awareness, 
understanding and acceptance; b) the ability to control behaviours when experiencing 
negative emotions; c) the use of non-avoidant emotion regulation strategies to modulate the 
intensity and/or duration of emotional responses; and d) the willingness to experience 
negative emotions as part of pursuing meaningful activities in life90. 
ERGT is a behavioural group treatment that includes elements from cognitive behavioural 
therapy and DBT. It is a short-term (16 weeks, although post-assessment is conducted after 
14 weeks) intervention delivered adjunctive to treatment as usual. ERGT targets NSSI 
directly through its proposed underlying mechanisms of emotion dysregulation and emotional 
avoidance102 and has shown effects on NSSI and other self-destructive behaviours, BPD-
symptoms, depression, anxiety, and emotion dysregulation101. However, ERGT has only been 
evaluated for adults treated in university settings in the United States, using expert therapists. 
Given the high prevalence of NSSI, it is important to evaluate novel treatments for NSSI that 
can be delivered by mental health professionals who work within the regular adult psychiatric 
care.  
Thus, implementing and evaluating ERGT in routine clinical care could increase patient’s 
availability to treatment for DSH and/or NSSI. Study III sought to evaluate the utility and 
feasibility of this ERGT when implemented in a Swedish psychiatric outpatient setting, 
involving 14 clinics around Sweden. 
 
2.2.2 Predictors of treatment response 
In introducing ERGT as a novel treatment in Sweden, it is important to identify prognostic 
factors (i.e. predictors) of treatment response and the patients most likely to benefit from the 
treatment103. The identification of predictors may help guide clinicians in recommending 
treatment interventions, and may also increase the overall rate of treatment responders as 
patients are better matched with treatment type. Also, it may be that the treatment needs to be 
adapted when delivered in a novel setting in order to enhance treatment effectiveness. 
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However, a limitation with studies on predictors is the lack of consistent findings. There is 
only one previous predictor study on ERGT, showing that higher levels of emotion 
dysregulation and baseline BPD-symptoms predicted greater improvements in BPD after 
treatment, and that higher levels of lifetime and 3-month NSSI predicted greater continued 
improvements in NSSI at post- and follow-up104. Study IV examined whether these results 
were generalizable when applied to ERGT in routine clinical care.  
 
2.3 SUMMARY OF THE BACKGROUND OF THE THESIS 
In conclusion, individuals with DSH or NSSI may represent a group with more impaired self-
control, which in turn may constitute an increased risk factor for both interpersonal violence 
and attempted and completed suicide. Thus, targeting aggression and emotion dysregulation 
seems warranted when treating individuals with NSSI, however, research on treatment, 
predictors and long-term outcomes of DSH and its association with interpersonal violence is 
lacking.  
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3 AIMS 
 
3.1 OVERALL AIM OF THE THESIS 
The aim of this thesis was to study deliberate self-harm (DSH) and nonsuicidal self-injury 
(NSSI) in a broader context, by investigating the association between self-harm and violence 
towards others; and by evaluating the utility and feasibility of a novel treatment intervention 
with established efficacy for NSSI not previously validated in Sweden. The specific aims of 
the individual studies are presented below: 
 
3.1.1 Study I 
The aim of Study I was to compare suicidal severity and experience of interpersonal violence 
in a group of suicide attempters with and without a history of NSSI. The hypothesis was that 
suicide attempters who also exhibited a history of NSSI would have more serious suicidal 
behaviours and report higher levels of interpersonal violence. 
 
3.1.2 Study II 
Study II aimed to investigate whether findings of Study I could be replicated in a larger 
sample. In this study, a unique association between DSH and perpetration of violence 
towards others was examined in a longitudinal, population-based national cohort study.  
 
3.1.3 Study III 
The aim of Study III was to evaluate the utility of emotion regulation group therapy (ERGT), 
a short, group-based emotion regulation behavioural treatment for NSSI, when implemented 
in routine clinical care. In an open pilot trial design, we hypothesized that participation in this 
ERGT would be associated with significant improvements in NSSI, other impulsive and 
destructive behaviours and psychiatric symptoms, and that these improvements would be 
maintained at six-months follow-up. 
 
3.1.4 Study IV 
Study IV sought to examine what patient characteristics were associated with outcome 
(emotion dysregulation and NSSI) in ERGT as evaluated in Study III. Specifically, we 
aimed to study if predictors previously identified in efficacy studies of ERGT conducted in 
the US could be replicated in a Swedish community-based sample.  
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4 METHODS 
 
4.1 DESIGNS, PRIMARY OUTCOMES AND ANALYSES 
The papers in this thesis include several different methodologies and methods of analysis. 
The specific design, primary outcomes and main statistical analyses of the different studies 
are presented below: 
 
4.1.1 Study I 
Study I was a cross-sectional clinical study, and included 100 patients with and without co-
occurring NSSI who had recently attempted suicide. The measures used were the Karolinska 
Suicide History interview (unpublished manuscript) assessing type and number of suicidal 
and non-suicidal acts; the Freeman Scale105 assessing the reversibility and interruption 
probability of the suicide attempt; and the Karolinska Interpersonal Violence Scale 
(KIVS;106) assessing childhood and adult exposure to and expression of violent behaviour. 
Experienced psychologists and psychiatrists conducted all interviews. Analyses of non-
parametric and parametric correlations were conducted using Spearman’s rho and Pearson’s 
r. A multiple linear regression was performed to predict lifetime violent behaviour from NSSI 
status. 
 
4.1.2 Study II 
Study II was a longitudinal, population-based register linkage study which included 
1 850 525 individuals, all Swedish citizens born between January 1, 1982 and December 31, 
1998 and living in Sweden at age 15. Exposure was defined as having received clinical care 
due to DSH as registered in the National Patient Register according to the ICD-9 or ICD-10 
between 1994 and 2013, and outcome was defined as having been convicted of a violent 
crime, according to the Swedish penal law. The mean follow-up time was 8.1 years (SD = 
4.7, range 0-17 years). Survival analyses of both gender specific and cohort-total risk and 
time-to-event were conducted through calculation of incidence rate ratios (IRR) and Cox 
proportional hazard rates (HR), with and without time-varying covariates and adjusted for 
familial clustering. As we sought to examine a shared predisposition to violence – whether it 
was directed toward oneself or against others, we also reversed all analyses, studying the 
association between individuals exposed to violent criminality and receiving clinical care due 
to DSH using the same methodologies as in the first set of analyses. 
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4.1.3 Study III 
Study III was a multi-site uncontrolled open pilot study of emotion regulation group therapy 
(ERGT), a 16-week long behavioural treatment targeting NSSI and emotion dysregulation. 
Assessments were conducted at pre- and post treatment and at six-month follow-up, and 
included 95 women with threshold or sub-threshold BPD and NSSI. Primary outcome was 
self-reported frequency of NSSI assessed with the DSHI13. Within-group effects were 
investigated using multilevel generalized estimated equations negative binomial regressions 
and general linear mixed regression models. 
 
4.1.4 Study IV 
Study IV was a prediction analysis, based on data from Study III. Primary outcomes were 
frequency of NSSI assessed with the DSHI and emotion dysregulation assessed with the 
DERS90. Demographic, clinical and diagnostic predictors and their association to the outcome 
measures were analysed using multilevel generalized estimated equation negative binomial 
regression and general linear mixed regression models. 
 
 
4.2 SAMPLE CHARACTERISTICS 
This thesis encompasses three different samples. Although the samples differ with respect to 
how they were included in the studies, whether they sought treatment or not, what diagnoses 
they had, and for how long they were followed, all three samples share one common 
characteristic – they engaged in self-harm. The specific characteristics and clinical correlates 
of the three samples are described below: 
 
4.2.1 Study I  
Study I included 80 adult participants, 52 women (65%) and 28 men (35%), mean age 34.7 
years (SD = 12.6, range 18-67). Participants were recruited between 2000 and 2005 after 
having attempted suicide, as part of their clinical follow-up at the Suicide Prevention Clinic, a 
specialized outpatient clinic for patients having attempted suicide, at the Karolinska 
University hospital in Stockholm. Of the 80 participants, 35 (44%) had engaged in NSSI, and 
that group was significantly younger and had more Axis II comorbidity, particularly BPD (ps 
< 0.001). The rate of substance use disorders and depression did not differ between the 
groups (ps > 0.6). 
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4.2.2 Study II 
Study II included 1 850 525 individuals, 900 143 (49%) women and 950 382 (51%) men, 
with ages ranging between 15 and 32. Of all included individuals, 55 185 (3%) had been 
exposed to clinical care due to deliberate non-fatal self-harm (ICD-codes E950-9 or X60-84) 
or an event of undetermined intent (ICD-codes E980-9 or Y10-34). The exposed group had 
significantly higher psychiatric comorbidity than the unexposed group (all ps < 0.001), and 
had particularly high rates of BPD (42 times higher than in the unexposed group), substance 
use and anxiety disorders (8 times higher), and bipolar disorder (12 times higher). 
 
4.2.3 Study III & IV 
Study III and IV included 95 adult women with a mean age of 25.1 years (SD = 7.0, range 
18-49). All participants were recruited by clinicians working at one of the 14 clinics included 
in the study. Participants were recruited either when seeking treatment at the clinic or from 
their regular treatment provider if they were already in treatment (that was not aimed 
specifically at treating self-harm) at the clinic. Of all the participants, 65 (68%) met full 
criteria for BPD whereas the remaining 30 participants (32%) met at least 3 criteria for BPD, 
including the criteria for suicidal or non-suicidal self-harm. Fifty-four participants (58%) had 
a history of suicidal behaviours (range 1-50), and 68 (72%) were taking psychotropic 
medication, and 80 participants (84%) had previously received psychosocial treatment at a 
mean length of 12.0 months (SD = 34.6). Also, comorbidity was high with 30-50% of the 
sample having co-occurring depression and anxiety disorders. 
 
 
4.3 ETHICAL CONSIDERATIONS 
The projects within this thesis include cross-sectional studies of clinical cohorts, registry-
based studies, and treatment intervention studies – all related to patients who engage in 
potentially life-threatening behaviours. This is an important area of research, as self-harm is 
common in Sweden and a strong predictor for future suicide attempts. However, as these 
patients engage in high-risk behaviours, few treatment studies have been conducted on this 
patient population, thus increasing the importance of these projects as well as the manner in 
which they are conducted. In conducting research on self-harming individuals, considerations 
regarding patient safety are of great importance.  
As Study I and II address sensitive information regarding co-occurring violence towards 
others, ethical considerations regarding stigmatizing an already vulnerable patient group must 
be made. In Study I, the assessment of interpersonal violence and NSSI was conducted 
within one month after an attempted suicide, thus requiring an especially considerate and 
respectful setting. Psychiatrists and psychologists experienced in working with suicidal 
individuals conducted all interviews, and all participants gave informed consent. Declining 
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participation in the study did not affect the clinical treatment of the patients at the Suicide 
Prevention Unit. 
In Study II, ethical approval was already in place as the collection of data began. The 
Department of Medical Epidemiology and Biostatistics has a comprehensive control system 
to ensure patient safety. Sweden is known for its registry based studies and the ability to link 
individuals through their personal identity number, and Swedish citizens have limited 
possibilities to decline registration in registers and thus participation in research. It is 
therefore of importance to not be able to detect particular groups of individuals in the dataset. 
Although all registry data have been anonymized and linked to a personal code rather than the 
personal identity number, in working with such sensitive data, the importance of collecting 
only data relevant to the research question was emphasized.   
There was close contact regarding patient safety and clinical care both in assessments around 
inclusion/exclusion as well as during treatment between the community clinicians, their 
directors and the research group in Studies III and IV. All participants gave informed 
consent and the study therapists informed all participants of their right to discontinue 
participation in research without this affecting their right to treatment, and what they may 
expect if they chose to participate in the research project. Further, screening, and assessment 
of severity of self-harm and suicidal ideation was thorough and – if the participant was 
included in the study – continuously monitored. This was done through a secure online 
website, where participants self-rated frequency of NSSI and suicidal urges each week. 
Therapists monitored participant’s ratings and addressed those with the patients if needed. 
This ensured patient safety and enabled the research group to include individuals who would 
not otherwise have been offered treatment in a treatment study as few treatment studies 
include patients at risk for suicidal behaviours. However, the regular assessments may also 
have been burdensome for the participants. There was great effort on the researchers part to 
select well-known and validated assessment tools in order to reduce this burden while at the 
same time maximizing patient safety. 
Further, in Study III, all sessions were filmed and reviewed weekly by the researchers, in 
order to assess the quality of the intervention given. This ensured some quality assurance for 
the participants, as well as enabled a more detailed supervision each week. However, this 
may also have had a negative impact on participants as patient integrity may have been 
affected. Special care was given to the security involved in uploading, reviewing and storing 
the filmed sessions. There is a continuous movement within the research field to increase and 
ensure research integrity, both in the conducting and reporting of clinical studies. Thus, 
Study III was registered in the ClinicalTrials.gov trial registry, and was reported in 
accordance with the TREND statement for non-randomised behavioural and public health 
interventions107.  
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5 RESULTS 
 
5.1 STUDY I 
Non-suicidal self-injury and interpersonal violence in suicide attempters 
Suicide attempters with a history of NSSI did engage in more severe suicidal behaviours and 
expressed more interpersonal violence than individuals only attempting suicide. Specifically, 
male suicide attempters with a history of NSSI had engaged in more violent suicide attempts 
(p = 0.04), and the more violent their attempted suicide was, the more NSSI they had engaged 
in (p = 0.04). Female suicide attempters with NSSI had engaged in more frequent suicide 
attempts than those without NSSI (p = 0.02). Also, suicide attempters with NSSI of both 
genders had used more interpersonal violence as adults compared to suicide attempters 
without NSSI (p = 0.003).  
 
5.2 STUDY II 
Association between deliberate self-harm and violent criminality 
In Study II a unique and significant association between DSH and violent criminality was 
found, and that association was significantly higher for violent crimes than non-violent 
crimes. In the cohort-total analyses, individuals exposed to care due to self-harm had a 5 
times higher crude hazard of being convicted of a violent crime than unexposed individuals. 
After controlling for relevant psychiatric comorbidity and socio-economic status the hazard 
remained significant and twice as high as for those not exposed to self-harm (HR 1.8, 95% CI 
1.8-1.9). Also, when ensuring that the exposure to self-harm preceded the violent crime 
conviction in the time-varying covariates analysis, the results remained and were somewhat 
elevated (HR 2.2, 95% CI 2.1-2.2). The gender specific analyses revealed gender specific 
patterns of risk and exposure, see Figure 2. Self-harming women showed an almost 8 times 
higher crude HR of criminal conviction during the follow-up period, irrespective of the 
timing of the self-harm episode, whereas exposed men had a four times higher hazard than 
unexposed men. When adjusting the gender specific analyses for all relevant psychiatric 
comorbidity and socio-economic status in the final analysis, the HR remained doubled 
compared to unexposed women (HR 2.1, 95% CI 2.0-2.3 when not controlling for the timing 
of the self-harm; and HR 2.3, 95% CI 2.1-2.5 when the timing of self-harm preceded the 
violent crime conviction). The reversed set of analyses revealed results were very similar to 
those in the main analysis described above.  
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Figure 2. Kaplan-Meier survival curve displaying time to violent crime conviction for 
exposed and unexposed men and women in Study II. N = 1 787 425. 
 
 
5.3 STUDY III 
Emotion regulation group therapy for deliberate self-harm: A multi-site evaluation in 
routine care using an uncontrolled open trial design 
Intent-to-treat analyses revealed that participation in ERGT was associated with a significant 
52% decrease in NSSI at post-treatment, and a 76% decrease from pre-treatment to six-month 
follow-up, see Figure 3. Further, there were significant improvements in other self-
destructive behaviours, emotion dysregulation, and psychiatric symptoms at post-treatment, 
associated with small to large effect sizes (Cohen’s d = 0.30–0.91), and these gains were 
either maintained or further improved upon at six-month follow-up. Attrition was low, with 
93% of the participants contributing with post-treatment assessments, and 82% contributing 
with six-month follow-up data. 
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Note. Pre = Pre treatment  Post = Post treatment  Fu6 = Six-month follow-up 
Figure 3. Reductions in NSSI frequency during treatment and follow-up in Study III. 
N = 95. 
 
 
5.4 STUDY IV 
Predictors of improvement in an open trial multi-site evaluation of emotion regulation 
group therapy 
Several demographic, clinical and diagnostic predictors of improvement in NSSI and emotion 
dysregulation were found when implementing ERGT in routine clinical care. Young age, 
more pre-treatment NSSI (during the six months before treatment start), higher BPD severity 
and higher rates of emotion dysregulation were associated with greater improvements in 
NSSI frequency during treatment or follow-up (all ps < 0.03). Higher emotion dysregulation 
and BPD severity was associated with greater improvement in emotion dysregulation during 
treatment and follow-up, respectively (p = 0.01 and p = 0.005). Co-occurring psychiatric 
disorders had a negative impact on patient’s maintenance of progress, as depression, PTSD 
and SAD was associated with an increase in self-harm and emotion dysregulation during 
follow-up (all ps < 0.01).  
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6 DISCUSSION 
 
Our findings suggest that both men and women who self-harm have an increased risk of 
being violent towards others, and that this risk is positively correlated with the severity or 
frequency of self-harm. Also, we found emotion regulation group therapy (ERGT) to be a 
useful and transportable treatment for self-harming individuals, although it may need some 
modification to help patients with comorbid disorders to maintain their gains. The findings 
are discussed below. 
 
6.1 STUDY I  
The findings from Study I adds to the literature on individuals engaging in both suicidal and 
non-suicidal self-injury (NSSI), and extended that knowledge to interpersonal violence as 
engagement in NSSI was significantly associated with the use of interpersonal violence as 
adults in both genders.  
This study indicates a possible gender specific pattern to suicidal behaviours, as women 
engaging in both suicidal and non-suicidal self-harm behaviours had more often attempted 
suicide compared to those only engaging in suicidal behaviour, and men engaging in both 
behaviours had more violent suicidal behaviours and the more violent the suicide attempt 
was, the more frequently they had engaged in NSSI. However, we did not find any 
association between NSSI and severity of suicidal intent or reversibility, suggesting that this 
association may be due to an impaired self-control, and a higher degree of impulsivity among 
individuals with NSSI. Trait impulsivity has been associated with aggression, NSSI, 
difficulties in emotion regulation and suicidality59,108 and the mediating role of impulsivity 
between NSSI, severe suicidal behaviour and interpersonal violence should be investigated in 
future studies. Also, suicide attempters with NSSI had a significantly higher rate of 
personality disorders, and may therefore represent a more severe patient group, thus 
confounding the association. The impact of personality disorders on suicidality is well 
established, with psychological autopsy studies suggesting that cluster B personality disorder 
in combination with impulsivity and aggression, differentiates those who died by suicide 
from those who did not109-111. However, when analysing the association with interpersonal 
violence in our sample, the multiple regression failed to find BPD to be significantly 
associated with interpersonal violence. As described above, BPD has been repeatedly 
associated with both suicidality and aggression, although a recent review questioned that, as 
they did not find BPD in the general population to be an independent predictor of violence112. 
However, this is an interesting finding in need of further investigation considering this was a 
clinically severe cohort. 
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6.1.1 Limitations and strengths of the study 
The results may be biased due to selection, as many individuals were not eligible for 
participation, did not agree to participate in the study or were lost to follow-up, thus limiting 
the generalizability of the study. However, the strength of this study is the thorough 
diagnostic assessment, the clinical and suicidal severity of the sample, and the in-depth 
assessment of suicidal and non-suicidal self-harm.  
 
6.1.2 Summary and future directions 
Taken together, the findings suggest a gradual increase in both suicidality and aggression, 
with NSSI contributing to a significant difference in expressed violence towards others, and a 
possible gender specific pathway to more severe suicidal behaviours. Further research is 
needed with a larger sample to investigate the impact of gender differences and psychiatric 
comorbidities on interpersonal violence. Also, investigating the co-occurrence of 
interpersonal violence and self-harm in a non-clinical population may further clarify this 
tentative association. 
 
 
6.2 STUDY II 
We conducted a population based longitudinal cohort study and found a significant and 
unique association between interpersonal violence and deliberate self-harm (DSH). We found 
gender specific associations with violence, particularly related to substance abuse. As 
expected, individuals exposed to DSH had significantly higher rates of psychiatric 
comorbidity compared to the unexposed group.  
 
6.2.1 Studying rare exposures and outcomes in registers 
Swedish registers are of high quality and coverage113,114. The use of registry based studies are 
powerful in the ability to gather large amounts of data and to study rare exposures, 
particularly when combining several registers as in Study II. Validation studies of the 
National Patient Register suggest that diagnoses are reliable when validated in chart 
reviews113,115-117. However, the disadvantages of register-based studies are the lack of 
specificity and the low resolution of the data collected. Only individuals that have been 
assessed and/or treated by somatic or psychiatric care will have a diagnosis registered. This is 
not a true estimate of the prevalence or incidence of psychiatric disorders in the population, as 
many individuals with psychiatric disorders do not seek treatment, and some that seek 
treatment do not receive a diagnosis although it may be warranted. When it comes to DSH, 
which has been referred to as the “hidden disorder”, we know that very few of those who 
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self-harm seek treatment. An international study investigating self-harm in > 30 000 
adolescents across Europe and Australia found the rate of treatment seeking to be as low as 
12.4% among those with self-harm (8.9% of the girls and 2.6% of the boys)118. In our study, 
3% of the cohort received clinical care due to self-harm during the follow-up period, a rate 
much lower than prevalence rates previously reported in community samples18,45,119,120, but in 
line with the Madge et al. (2008) findings.  
However, violent crime convictions are also rare outcomes, and most violent or aggressive 
acts (of a lesser severity than homicide) are never reported or prosecuted. This is particularly 
relevant as crimes related to interpersonal violence where perpetrator and victim know each 
other are unrecorded to a higher extent than crimes committed by strangers121. Thus, in this 
study, selection bias is affecting both the exposure and the outcome variable, but in ways 
unrelated to each other, therefore the estimates may be conservative, but the strength of their 
mutual association should be correct.  
 
6.2.2 Is it reasonable to suggest we studied “NSSI” and interpersonal 
violence? 
The simple answer is no (and yes). What we did study is DSH, in other words, both suicidal 
and non-suicidal self-harm. Previous Swedish registry based studies on intentional self-harm 
codes (E950-E959 and X60-X84) and events of undetermined intent (E980–E989 andY10-
Y34) have analysed the data as attempted suicides, mainly including data from patients 
treated at inpatient clinics and hospitals. In this study, over 50% of our data came from 
outpatient clinics, which makes it reasonable to conclude that both NSSI and attempted 
suicides are included in this study (i.e., DSH). We believe that there is a qualitative difference 
to having an instance of DSH registered when seeing a psychiatrist at a specialized outpatient 
clinic, compared to having it registered at a somatic or psychiatric hospital or emergency 
department. We undertook several sensitivity analyses in order to analyse different degrees of 
lethality associated with self-harm, and found that higher degrees of lethality of the self-harm 
was associated with higher hazards of having a violent crime conviction (HR 4.3–10.2). Also, 
we did find a stronger association between violent crime and intentional self-harm codes 
compared to events of undetermined intent, suggesting that when clinicians register an 
intentional self-harm event, it is qualitatively different than when intent is unknown. Again, 
there seems to be a strong positive correlation between severity of DSH and violence. It may 
be hypothesized that our study also caught individuals engaging “only” in NSSI and their 
association with violent crimes. However, it is important to note that we only included the 
first record of DSH, so exposed individuals having a “low-lethality” DSH (i.e., potential 
NSSI) registered, may have self-harmed in a more severe manner during follow-up, without 
this information being included in the study. On the other hand, most exposed individuals 
only had one record of DSH during follow-up (median 1, mean 1.9, SD = 3.2, range 1–173).  
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Did we study interpersonal violence? Here, the answer is also complex. Regarding the 
sampling of crime convictions from the Crime register, it is important to note that a person 
may be convicted of several crimes at any one time. We selected the first registered offence 
for each individual. This implies that the association with a particular crime for a particular 
individual is unspecific, and does not provide much information on an individual level. 
Nevertheless, the most common offences in this population were crimes against liberty and 
peace and crimes involving public danger. We also conducted sensitivity analyses comparing 
the association between DSH and violent and non-violent crimes. In those analyses, an 
individual convicted of both types of crimes would serve as his or her own control, so to 
speak. Thus, on a population level, we did study crimes involving interpersonal violence, and 
we found a stronger association between violent crimes and DSH than non-violent crimes.  
Taken together with other evidence of the interpersonal difficulties in both violent and self-
harming individuals, and the established risk of interpersonal conflicts triggering both violent 
and self-harming acts122, it is reasonable to suggest that there is an increased risk of 
interpersonal violence in self-harming individuals, and vice versa. The association is complex 
and involves interactions between social, behavioural and neurological factors, and future 
studies need to assess the specific conditions under which an individual engages in both types 
of behaviours. 
 
6.2.3 DSH, violent crime and psychiatric comorbidities  
Although we were able to establish a statistically significant association between DSH and 
violent crime, only 14.7% of the exposed individuals were convicted of a violent crime (n = 
8 155). So what characterizes individuals exposed to self-harm that were also violent in our 
cohort? When analysing the distribution of psychiatric comorbidities across those convicted 
of a violent crime and those who were not, individuals with DSH and a violent crime 
conviction had a significantly higher rate of psychiatric comorbidity for all diagnoses except 
BPD, bipolar disorder, eating disorder and depression (see Table 1). Notably, ASPD, ADHD 
and substance use disorders was much more common among those convicted (ps < 0.001).  
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Table 1. Psychiatric comorbidities in self-harming individuals convicted of a violent crime 
compared to those not convicted of a violent crime. 
  Exposed to self-harm (N = 55 185)   
 
Psychiatric 
diagnosis 
 
Violent crime 
conviction 
n = 8 155 
 
No violent crime 
conviction 
n = 47 030 
 
X2 df(1) 
 
p 
BPD 727 (8.8%) 3 979 (8.5%) 1.144 ns 
ASPD 213 (2.59%) 83 (0.18%) 762.950 < 0.001 
SUD 5 023 (61.02%) 12 523 (26.67%) 3.8e+03 < 0.001 
ADHD 2 411 (29.29%) 5 290 (11.12%) 1.9e+03 < 0.001 
Psychotic disorders 746 (9.06%) 1 853 (3.95%) 408.435 < 0.001 
Bipolar disorder 522 (6.34%) 2 928 (6.24%) 0.132 ns 
Depression 2 688 (32.65%) 14 935 (31.81%) 2.299 ns 
Anxiety disorders 3 917 (47.58%) 17 248 (36.73%) 348.607 < 0.001 
Eating disorders 190 (2.31%) 2 983 (6.35%) 211.482 < 0.001 
Autism 593 (7.20%) 2 061 (4.39%) 121.158 < 0.001 
Note. BPD = Borderline personality disorder ASPD = Antisocial personality disorder SUD = Substance use 
disorders ADHD = Attention–Deficit Hyperactivity Disorder 
 
This is in line with earlier findings that ASPD and substance use disorders are significantly 
associated with violence in community, forensic and psychiatric samples35,123-125. It has been 
found that specifically for women, comorbid ASPD and substance use disorders increase risk 
substantially for committing violent acts79,126,127. It has been suggested that women have a 
higher threshold to cross before using interpersonal violence, as social norms limit the display 
of violence in women to a higher extent than in men128. This would indicate that female 
violence perpetrators have a higher clinical (i.e., more severe psychiatric comorbidity) and 
trauma-related (i.e., higher degree of childhood sexual abuse, victims of domestic violence) 
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burden before becoming violent compared to male perpetrators78,80. However, as we did not 
control for the timing of the diagnoses in this study, we do not know if substance use 
disorders were diagnosed in association with the self-harm event, or at a later time point, thus 
representing a progression of clinical severity. However, it is clear that substance use had an 
effect on the association between DSH and violence in this cohort, which is in line with 
several studies on self- and other directed violence42,124,126,127,129,130. Studies on DSH from the 
UK have found that men are more likely to self-harm when intoxicated, which may explain 
the high percentage of exposed men in our study, perhaps receiving clinical care for DSH in 
association with intoxication. Lately, research has shown that this risk has increased for 
women during the past decade compared to earlier studies46,131, and as previously noted, a 
recent study showed that alcohol use has risen as a self-reported problem among adults 
presenting at emergency departments due to DSH44. Thus, substance use is an increasing 
problem among individuals with DSH, and seems to increase risk for violence towards 
others. This association needs to be further explored, and assessment of and interventions for 
both aspects of violence and substance use disorders need to be developed.  
Impulsivity – in the form of ADHD – was more common among exposed individuals 
convicted of a violent crime. ADHD has repeatedly been associated with violence132, 
substance abuse133 and DSH134. It is also a part of the “impulsive aggressive”-traits studied in 
the co-occurrence of self-harm and violence and suggested to be a trait connecting these 
behaviours59. Although as impulsivity is a difficult term to define, findings are inconclusive 
as of yet63. However, it is not surprising that this diagnosis is more common among our 
convicted and exposed individuals.  
 
6.2.4 Shared vulnerabilities and maintaining mechanisms revisited 
What drives interpersonal violence? The George et al (2006) study makes for an interesting 
hypothesis in linking aggressive behaviours to fear conditioning and avoidance, and 
describing a pathway to violence through a heightened sensitivity to environmental stimuli, 
similar to Linehan’s biosocial theory12 and the EAM85. The perpetrators admitted to either 
striking their significant other, the wall or cutting themselves, as an attempt to relieve anxiety 
and racing thoughts. Alcohol and drugs helped them relax but also increased the speed with 
which aggression occurred, and increased the likelihood of reacting with fight, rather than 
flight. They also displayed affective instability, rapidly shifting moods and had psychiatric 
disorders within anxiety disorders and personality disorders94. Thus, there is a high degree of 
similarities in individuals engaging in domestic violence and in self-harm, particularly when 
comorbid with BPD. It is unclear though, how generalizable these findings are to individuals 
convicted of violent crimes. Violence is – just as self-harm – a heterogeneous concept with 
many levels of severity, making it difficult to assume that all individuals who are violent are 
driven by the same mechanisms. On the contrary, different classifications are made within 
this field, for instance between reactive (i.e., impulsive aggression) and proactive (i.e., 
predatory aggression more associated with psychopathic traits) aggression60. However, 
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emotion regulation difficulties in violent individuals should be further explored, particularly 
since the characteristics of individuals engaging in violent and self-harm behaviour may be 
more similar across genders than previously thought. 
 
6.2.5 Limitations and strengths of the study 
As previously noted, the limitations of this study are the low resolution of the variables 
studied, and the potential risk of misclassification and underreporting of DSH in the 
registries. However, the strengths are the large sample size, the stringent definition of both 
the exposure and outcome (uncommon in studies of both DSH and violence, where – as 
previously noted – a multitude of definitions exist), and the possibility to study gender 
differences. Another strength is that the population in Study II was “non-clinical”, in the 
sense that those exposed were not selected from a clinical setting (although it is important to 
note that we do not know if or how much treatment any of them had received).  
 
6.2.6 Summary and future directions 
It is reasonable to conclude that self-harm is associated with aggression. This adds to the 
previous literature on the association between suicide and aggression and extends it to DSH 
and NSSI, although we still do not know why or when they co-occur. The findings suggest 
that self-harm behaviours may be best conceptualized on a continuum, and that different 
levels of risk factors or clinical burden are associated with a higher suicidal – and violent – 
severity. Several such risk factors have been identified, either as distal or proximal risk 
factors. Childhood maltreatment and abuse is such an established distal risk factor for both 
violence and self-harm37,135,136. Psychiatric comorbidity is another risk factor, which seem to 
be as prevalent in DSH and NSSI as in suicide completers35, although not enough in itself, as 
the majority of individuals with psychiatric disorders neither self-harm nor commit violent 
acts. Other risk factors are substance abuse as described above, and personality disorders, 
which contributes to a higher risk, as they are indicative of higher psychiatric burden. Also, 
personality traits such as impulsivity, aggression and emotion regulation difficulties may 
have unique contributions to the co-occurrence of these behaviours. Further research is 
needed to disentangle this interaction, preferably in a path-analysis where their competing 
effect may be investigated. 
 
 
6.3 STUDY III AND IV 
Study III was an intervention study, using an open pilot, uncontrolled design, aiming to 
study the feasibility and acceptability of a group-based, adjunctive treatment for NSSI. We 
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found significant reductions in NSSI, emotion dysregulation and psychiatric symptoms, and 
these results were maintained or further improved upon at six-month follow-up. 
As this was an uncontrolled study, there are some inherent difficulties in interpreting the 
findings. The lack of a control group essentially precludes drawing conclusions about the 
treatment’s effectiveness, although many factors suggest that ERGT in routine clinical care is 
a useful treatment for NSSI. 
First, it is possible but unlikely that a 52% reduction in frequency of NSSI would occur 
spontaneously in the course of 14 weeks, as found at post-treatment. Our findings are 
strikingly comparable to previous ERGT studies, and when comparing the waitlist controls in 
the two randomized controlled trials of ERGT that have been conducted, they showed a 50% 
increase in NSSI at post-treatment in the first study99, and a 5% reduction in the second 
study101. This comparison makes it likely that participation in ERGT may have contributed to 
this reduction, however we cannot know for sure. Second, there was a significant and 
continued reduction in NSSI during follow-up, which one could hypothesize was due to a 
continued use and efficiency of the emotion regulation strategies learned during treatment. 
Further, a high percentage of participants contributed with post-treatment and six-month 
follow-up assessments (93% and 82% respectively), thus including data from participants 
who dropped out of treatment. However, future studies need to evaluate ERGT in routine 
clinical care in a randomized controlled design to control for effects of time, attention and 
other non-specific effects of being in a treatment intervention study.  
 
6.3.1 Aggression in the ERGT-study 
We did not assess the use of interpersonal violence in Study III. Conducting complementary 
analyses where aggression was measured with a composite variable consisting of criteria no 8 
in SCID-II; Inappropriate, intense anger or difficulty controlling anger (e.g., frequent 
displays of temper, constant anger, recurrent physical fights)137, criteria no 9 in Borderline 
Symptom List; during the past week I had uncontrollable angry outbursts or attacked others 
physically [at least 2-3 times]138 and criteria no 10 from Inventory of Interpersonal Problems 
– BPD; I am too aggressive towards others139. The composite variable ranged from 1–3 and 
showed a significant association with BPD-severity (b = 0.88, SE = 0.24, p < 0.001, see 
Figure 4). 
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Figure 4. Association between levels of aggression and number of borderline personality 
disorder (BPD) criteria in participants from Study III. N = 95 
 
However, as previously noted, it is difficult to draw any conclusions from this, as this was not 
formally assessed with a structured assessment enabling us to compare our sample with 
others. However, this may add to findings of BPD being associated with aggression in more 
clinically severe cohorts and needs to be further investigated. 
 
 
6.3.2 Clinical value of the implementation and evaluation 
There are several important clinical findings and strengths in an effectiveness study such as 
Study III, and one of those is the external validity. Twenty-eight community clinicians of 
different professional backgrounds delivered the ERGT after receiving a three-day training in 
ERGT. Also, patients were recruited at their local clinics and received ERGT as part of their 
standard treatment. And although the sample may to some extent have been a convenience 
sample, as probably not all participants eligible for study inclusion were assessed, the 
included participants seemed – from a clinical perspective – to be representative of self-
harming and treatment seeking patients with BPD or sub threshold BPD within Swedish 
outpatient psychiatric care.  
0
1
2
3
Ag
gr
es
sio
n 
pr
on
en
es
s
2 4 6 8 10
No of BPD-criteria
Fitted values Level of aggression
 34 
The ERGT evaluation and implementation in routine clinical care offered several other 
important advantages in the treatment and assessment of individuals with NSSI. First, 
clinicians were taught how to assess and monitor multiple forms of NSSI with structured 
measures. This is important as a national survey assessing NSSI in 1717 patients at 84 
Swedish adolescent and adult outpatient clinics showed that one third of the individuals who 
self-harmed did not tell their treating clinician about this140. Second, the baseline assessment 
of eligibility included structured assessment of patient’s psychiatric comorbidity before 
treatment start, and a thorough suicidal anamnesis and risk assessment. Third, helping the 
clinicians conduct research in their own clinical setting was often challenging as their 
workload was increased, but it also raised their awareness of how collecting structured data 
can generate knowledge, and inform treatment interventions. For instance, therapists were 
able to track participants’ NSSI frequency through the internet-based weekly assessments, 
thus enabling them to monitor each participant’s progress or lack thereof. Fourth, this study 
increased access to treatment for self-harming individuals. Having a treatment that targets 
NSSI available at one’s clinic may increase the “non-ERGT” clinician’s likelihood to ask 
about self-harm, as research shows that clinicians often feel frustrated or hopeless and do not 
know how to help self-harming patients141. Finally, we do hope that participants experienced 
ERGT to be helpful. We know that some participants felt that the treatment was stressful, due 
to it being delivered in a group setting, whereas others felt that that was its greatest strength – 
meeting others struggling with NSSI made them feel validated and “normal”. And although it 
was scary to talk about emotions in group, it was perceived as helpful. Interestingly, 
participants rated treatment credibility and expectancy of improvement142 after session one 
lower than in previous ERGT studies (mean credibility 5.7, and expectancy 47%, compared 
to mean credibility 6.9 and expectancy 59% in100), although dropout rates were similar 
(22%)99-101. This may have been due to the fact that our therapists were to a lesser extent 
“experts” in ERGT, but also that the treatment was given within their regular psychiatric 
clinic.  
The transportability and brevity of ERGT and the relative ease with which it was 
implemented into routine clinical care, as well as the promising results on NSSI makes us 
conclude that increasing the availability of ERGT will benefit self-harming patients. The 
research group has continued to train new clinicians in ERGT (120 therapists and 12 
supervisors) since the first ERGT workshop in 2013. We have also authored guidelines on 
how to best implement ERGT into one’s clinic, so as to ensure safe and qualitative delivery 
of the treatment. 
Finally, the prediction analysis (Study IV) indicated that ERGT might also be suitable for 
individuals with more severe difficulties in emotion dysregulation and NSSI, thus extending 
the knowledge on its eventual usefulness in routine clinical care. However, robust predictors 
are difficult to find across studies, as studies seldom are designed to investigate predictors but 
outcomes. In an attempt to strengthen the theoretical basis for Study IV, we chose to 
investigate previously identified predictors of treatment response in ERGT, but were only 
able to replicate some of the earlier findings, such as NSSI frequency and BPD-severity104 as 
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significant predictors. However, this was also due to the fact that several measures used in the 
Gratz et al (2014) study were not included in our study.  
 
6.3.3 Limitations and strengths of the studies 
There are several limitations to Study III and IV. As previously noted, the lack of a control 
group limits our ability to draw any firm conclusions of the effect of ERGT in our sample. 
Also, as described above, there is also a risk of selection bias in the recruitment of 
participants to the study, as individuals with more severe psychopathology may not have been 
asked to participate in the study. We did not conduct thorough assessment of personality 
disorders and used the MINI-screen interview at the initial assessment. This may have 
inflated rates of axis I diagnoses which would be relevant to, and possibly bias the findings in 
Study IV. Finally, we only included women, which limits generalizability of the study 
results. Future studies need to investigate the usefulness of ERGT for males with DSH.  
 
6.3.4 Summary and future directions 
From a clinical perspective, ERGT fills an important treatment gap in psychiatry. It is a short, 
clinically feasible treatment that can be combined with any version of treatment as usual, and 
it targets NSSI specifically through the teaching of more effective emotion regulation 
strategies. Such treatment has been lacking, and as NSSI (and DSH) seem to become more 
prevalent, it is more important than ever to increase access to treatment. More research is 
needed, and perhaps some modifications would increase its usefulness further, specifically for 
patients with aggressive or violent behaviours. 
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7 CONCLUSIONS AND FUTURE DIRECTIONS 
 
The findings from the studies included in this thesis suggest that there is an association 
between self-harm and violence towards others. Assessments and treatment interventions 
need to target both these behaviours, possibly through treatments focusing on increasing 
emotion regulation skills. Emotion regulation group therapy is a promising and transportable 
treatment for NSSI and could fill a treatment gap for individuals struggling with NSSI.  
Future studies need to examine the specific pathways to co-occurring violence and self-harm, 
as risk factors such as higher psychiatric complexity, higher levels of self-reported aggression 
and childhood abuse are important but not unique contributors to both behaviours. An 
interesting topic for future studies could be to investigate whether difficulties in emotion 
regulation are relevant in violent and aggressive individuals, and if treatment targeting 
emotion regulation could be helpful for them. 
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